sitagliptin glp 1 agonist GLP-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician? Clinical Focus on GLP-1 Agonists
Description
SOLIQUA [soh LEE kwa] combines lixisenatide with insulin glargine (Lantus)
Ensuring efficacy, safety, and durability comparable to injectable GLP-1 RAs while minimizing adverse effects, particularly gastrointestinal discomfort, is essential
& Morimoto, C
The drugs blunt the hit we get from these foods, and they start to lose their grip on us
Comparative efficacy of pharmacologic therapies for MASH in reducing liver fat content: systematic review and network meta-analysis
